Aytu BioScience Inc (NASDAQ:AYTU)

Aytu BioScience Inc (NASDAQ:AYTU)

Share Price
$ 1.74
-0.09 (-4.92 %)
Market Cap
$28.99 m
Proactive Investors - Run By Investors For Investors

Aytu BioScience Inc

Aytu BioScience is a specialty healthcare company focused on developing and commercializing novel products in the field of urology. Aytu is initially concentrating on prostate cancer, male sexual dysfunction and male infertility and plans to expand into other urological indications for which there are significant medical needs.

The company currently markets ProstaScint® (Capromab...

52-week High/Low: $7.80 / $0.69
Sector: Aerospace
Market Cap: $28.99 m
Website: aytubio.com
col 3
col 4
col 5
col 6

Aytu BioScience Inc Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use